INVESTMENT BANKING ENGAGEMENT AGREEMENTInvestment Banking Engagement Agreement • June 9th, 2014 • DelMar Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
National Securities, Corp. (“National”) is pleased to provide on a non-exclusive basis investment banking and financial advisory services to DelMar Pharmaceuticals, Inc. (the “Company”) with respect to 1) advising the company on ways to optimize their available financial alternatives including but not limited to the potential solicitation of existing warrant holders 2) strategic introductions, potential joint venture opportunities and assisting the Company in developing a well-coordinated and integrated plan to address ways in which the Company can seek to increase its visibility within its markets, enhance its liquidity and establish non deal roadshows on the terms and conditions in this letter agreement (the “Agreement”) and 3) any other general advisory services that the Company may seek to pursue and avail themselves of.
FIRST AMENDMENT TO WARRANT TO PURCHASE COMMON STOCKPurchase Common Stock • June 9th, 2014 • DelMar Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This First Amendment (the “ Amendment ”) to Warrant to Purchase Common Stock (the “ Warrant ”), is made and entered into effective as of June 9, 2014 (the “ Effective Date ”), by and between DelMar Pharmaceuticals, Inc., a Nevada corporation (the “ Company ”) and the undersigned (the “ Holder ”). Capitalized terms used but not otherwise defined herein shall have the same meanings as set forth in the Warrant.
INVESTMENT BANKING ENGAGEMENT AGREEMENTInvestment Banking Engagement Agreement • June 9th, 2014 • DelMar Pharmaceuticals, Inc. • Pharmaceutical preparations
